This week’s Research Ethics Roundup looks at the first known US-based attempt of changing the DNA of embryos with CRISPR, the results of a large-scale wellness study, why researchers are challenging the notion that pregnant women are a “vulnerable” research population, and why European researchers are choosing to be transparent about their research with animals. Read more
TAG ARCHIVES FOR research ethics roundup
This week’s Research Ethics Roundup looks at why the elderly continue to be underrepresented in clinical research, how a massive government study is working on community engagement efforts, the Food and Drug Administration (FDA)’s plan for new patient-focused drug development guidance, and a European Union committee’s opinion that nonhuman primate research should continue in its member countries. Read more
This week’s Research Ethics Roundup the ramifications of only using male lab mice in preclinical research, why so few lab chimpanzees have been sent to sanctuaries, Public Citizen’s letter to the Department of Health and Human Services (HHS) on new SUPPORT trial findings, and the ethics of pricing a Zika vaccine. Read more
This week’s Research Ethics Roundup looks at the latest US Department of Agriculture (USDA) numbers on animals living in research labs, how researchers are working to better engage diverse populations, President Trump’s decision to keep Dr. Francis Collins as director of the National Institutes of Health (NIH), and the International Committee of Medical Journal Editors (ICMJE)’s final policy on data sharing statements for clinical trials. Read more
This week’s Research Ethics Roundup reviews a Congressional hearing on reducing overhead payments for research oversight, highlights doctors’ arguments for saving the Fogarty International Center at the National Institute of Health (NIH), discusses legal challenges faced by the US Department of Agriculture (USDA) over their decision to delay reposting animal welfare records, and outlines a proposal that allow human subjects to negotiate with the pharmaceutical industry on drug pricing issues.
House Science Panel Joins Trump in Questioning Research Overhead Payments
Jeffrey Mervis reports for Science on a recent Congressional hearing in which representatives reviewed the [...] Read more